What is the latest verdict amount against Johnson & Johnson?

The verdict was $10.2 million in a mesothelioma case linked to talc products.

How have talc lawsuits affected JNJ stock?

Despite lawsuits, the stock rose 13% YTD and 55.84% over one year.

What is Johnson & Johnson's stance on talc lawsuits?

The company denies asbestos in its products and is pursuing a comprehensive settlement via bankruptcy.

Did Johnson & Johnson recently raise its financial guidance?

Yes, the company raised its guidance, reflecting management's confidence in operational performance.

Johnson & Johnson Faces $10.2M Verdict in Talc Litigation

A Minnesota jury included Johnson & Johnson in a $10.2 million mesothelioma verdict tied to asbestos-contaminated cosmetic talc. Despite litigation, JNJ stock has risen 13.02% year-to-date and 55.84% over one year.

Johnson & Johnson (JNJ) faces renewed legal pressure after a Minnesota jury ordered the company to pay $10.2 million in a mesothelioma case linked to asbestos-contaminated cosmetic talc products. The verdict adds to the company's broader talc-related legal exposure.

Verdict Details

The jury found that talc products containing asbestos caused the plaintiff's mesothelioma, a rare cancer of the lung lining. The $10.2 million award adds to a series of previous verdicts against the company.

Company Response

Johnson & Johnson continues to defend its products, stating they are asbestos-free and safe. The company is pursuing a comprehensive settlement through a subsidiary's bankruptcy plan.

Legal Context

The company faces thousands of lawsuits over talc products, with previous verdicts totaling billions. However, many are under appeal.

Stock Impact

Despite negative headlines, JNJ shares have delivered a 13.02% year-to-date return and a 55.84% one-year total shareholder return, indicating strong momentum.

What This Means for Investors

Investors should monitor litigation developments closely, especially the bankruptcy settlement attempt. The recent guidance raise reflects management's confidence in operational performance despite legal risks.